In summary, GDM patients treated with insulin during pregnancy presented with a worse metabolic profile and elevate inflammation, including significantly higher BMI compared to GDM women without insulin treatment and Ctrl participants, and were at higher risk to develop prediabetes. The gene discussed is INS; the disease is prediabetes syndrome.